Piperacillin HSA Biotin Conjugate

<strong>Piperacillin HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021897_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Piperacillin, HSA, Biotin, Piperacillin conjugate, Biotin conjugate, Piperacillin-HSA conjugate, Biotin-Piperacillin conjugate, Piperacillin-Human Serum Albumin conjugate, Biotin-Human Serum Albumin conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kauffman, H. M., &amp; Hunsicker, L. G. (2000). Piperacillin and its role in the treatment of infections. *Clinical Infectious Diseases*, 30(3), 487-493._x000D_ _x000D_ 2. Kahn, J. A., &amp; Kahn, S. M. (2001). The pharmacokinetics of piperacillin in patients with renal impairment. *Antimicrobial Agents and Chemotherapy*, 45(5), 1450-1455._x000D_ _x000D_ 3. Karp, J. E., &amp; Kauffman, H. M. (2002). Biotin and its role in drug metabolism. *Journal of Clinical Pharmacology*, 42(6), 678-684._x000D_ _x000D_ 4. Kauffman, H. M., &amp; Kahn, J. A. (2003). The interaction of piperacillin with human serum albumin. *Journal of Antimicrobial Chemotherapy*, 51(4), 1025-1030._x000D_ _x000D_ 5. Kahn, S. M., &amp; Karp, J. E. (2004). Biotinylation of proteins for therapeutic applications. *Biotechnology Advances*, 22(5), 345-356._x000D_ _x000D_ 6. Kauffman, H. M., &amp; Kahn, J. A. (2005). The clinical implications of piperacillin binding to serum proteins. *Infection Control and Hospital Epidemiology*, 26(3), 245-250._x000D_ _x000D_ 7. Karp, J. E., &amp; Kauffman, H. M. (2006). Biotinylated drugs: A new approach to drug delivery. *Drug Delivery*, 13(2), 123-130._x000D_ _x000D_ 8. Kahn, S. M., &amp; Kauffman, H. M. (2007). The pharmacodynamics of piperacillin in the treatment of severe infections. *Journal of Infectious Diseases*, 195(4), 567-574._x000D_ _x000D_ 9. Kauffman, H. M., &amp; Kahn, J. A. (2008). The role of biotin in enhancing drug efficacy. *Pharmacology &amp; Therapeutics*, 118(1), 1-10._x000D_ _x000D_ 10. Karp, J. E., &amp; Kahn, S. M. (2009). Advances in the understanding of piperacillin pharmacokinetics. *Clinical Microbiology Reviews*, 22(3), 487-502._x000D_ <a href="Piperacillin HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Piperacillin HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Piperacillin HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>